Skip to content
Oncology Research Hub

North Carolina

Cancer clinical trials in North Carolina

429 cancer studies are recruiting participants at sites in 60 cities across North Carolina as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse North Carolina by city

Cities with the most studies recruiting right now.

Every North Carolina city with a recruiting study

By research area: Breast Cancer (120), Lymphoma (106), Lung Cancer (103), Prostate Cancer (52), Melanoma (24), Pancreatic Cancer (24).

Durham (182), Chapel Hill (130), Charlotte (89), Winston-Salem (79), Greenville (28), Pinehurst (28), Huntersville (26), Raleigh (20), Goldsboro (19), Asheville (18), Clinton (16), Jacksonville (16), Hendersonville (14), Wilson (14), Clemmons (12), Concord (12), Gastonia (12), Greensboro (12), Matthews (11), Monroe (11), Salisbury (11), Cary (10), Kernersville (9), Albemarle (8), Asheboro (8), Burlington (8), Forest City (8), Mooresville (8), Mount Airy (8), Reidsville (8), Hillsborough (7), Shelby (7), Thomasville (7), Lincolnton (6), New Bern (5), Statesville (5), High Point (4), North Wilkesboro (4), Clyde (3), Fayetteville (3), Weaverville (3), Wilmington (3), Garner (2), Morehead City (2), Morrisville (2), Rocky Mount (2), Stateville (2), Wilkesboro (2), Boone (1), Carrboro (1), Henderson (1), Hickory (1), Kannapolis (1), Kinston (1), Laurinburg (1), Lumberton (1), Nags Head (1), Research Triangle Park (1), Smithfield (1), Supply (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in North Carolina

Basic details from each study's public record (the 12 most recently updated of 429). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    LeonaBio
    Recruiting in
    Durham
    Registry record
    NCT05696626 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in North Carolina on ClinicalTrials.gov.

Lung cancer: recently updated in North Carolina

  1. Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teligene US
    Recruiting in
    Pinehurst
    Registry record
    NCT05168566 · updated
  2. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Cary
    Registry record
    NCT06216301 · updated
  3. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlotte · Concord · Winston-Salem
    Registry record
    NCT06287775 · updated
  4. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Asheville · Chapel Hill · Raleigh
    Registry record
    NCT07513376 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in North Carolina on ClinicalTrials.gov.

Prostate cancer: recently updated in North Carolina

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Durham
    Registry record
    NCT04038502 · updated
  2. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Durham · Salisbury
    Registry record
    NCT05011383 · updated
  3. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Kinston
    Registry record
    NCT04423211 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in North Carolina on ClinicalTrials.gov.

Melanoma: recently updated in North Carolina

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Cary · Durham · Raleigh
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in North Carolina on ClinicalTrials.gov.

Lymphoma: recently updated in North Carolina

  1. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Chapel Hill · Charlotte · Clemmons · and 11 more U.S. locations
    Registry record
    NCT06724237 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Durham · Winston-Salem
    Registry record
    NCT07221500 · updated
  3. ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Newave Pharmaceutical Inc
    Recruiting in
    Durham
    Registry record
    NCT07342478 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call